LAMIVUDINE

Course overview

LAMIVUDINE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HIV-1 AND HEPATITIS B. IT IS IN THE NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI) CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR LAMIVUDINE AS A VALUABLE AGENT IN THE THERAPY FOR HIV (AND OTHER DISORDERS WHEN APPLICABLE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE CARE OF PATIENTS WITH HIV AND HEPATITIS B.